misitatug blivedotin (RC88) / Rongchang Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
misitatug blivedotin (RC88) / Rongchang Pharma
NCT05508334: A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours

Recruiting
1
81
RoW
RC88, The injectable RC88
RemeGen Co., Ltd.
Advanced Solid Tumours
06/24
12/24

Download Options